KCTD15: A Protein of Interest as A Drug Target and Biomarker (G79047)

Target Name: KCTD15

NCBI ID: G79047

KCTD15

Other Name(s): BTB/POZ domain-containing protein KCTD15 | potassium channel tetramerization domain containing 15 | Potassium channel tetramerization domain containing 15, transcript variant 1 | MGC25497 | potassium channel tetramerization domain-containing protein 15 | KCTD15 variant 1 | Potassium channel tetramerisation domain containing 15 | potassium channel tetramerisation domain containing 15 | Potassium channel tetramerization domain-containing protein 15 | MGC2628 | KCD15_HUMAN | BTB/POZ domain-containing protein KCTD15 (isoform 1)

KCTD15: A Protein of Interest as A Drug Target and Biomarker

KCTD15 is a protein that is expressed in a variety of tissues throughout the body, including the brain, spleen, and thymus. It is a member of the BTB/POZ domain family of proteins, which are known for their ability to interact with the protein PSF2 and form a complex called PSF2-KCTD15.

The PSF2-KCTD15 complex plays a role in the regulation of cellular processes that are important for cell survival and growth, including cell adhesion, migration, and invasion. The complex is thought to function as a negative regulator of the Wnt signaling pathway, which is a critical pathway that is involved in the development and maintenance of tissues and organs.

KCTD15 has also been shown to play a role in the regulation of theNotch signaling pathway, which is involved in the regulation of cell survival and differentiation. The Notch signaling pathway is thought to be involved in the development and maintenance of tissues and organs, and is often disrupted in a variety of diseases, including cancer.

In addition to its role in the regulation of the PSF2 and Notch signaling pathways, KCTD15 has also been shown to play a number of other roles in the regulation of cellular processes that are important for cell survival and growth. For example, it has been shown to play a role in the regulation of cell cycle progression, and has been shown to interact with the protein p21 (CKAP2).

KCTD15 is also of interest as a potential drug target. The PSF2-KCTD15 complex is thought to be involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs, and may be a useful target for the development of new drugs for a variety of diseases.

In addition to its potential as a drug target, KCTD15 is also of interest as a biomarker. The PSF2-KCTD15 complex is thought to play a role in the regulation of cellular processes that are important for the development and maintenance of tissues and organs, and may be a useful biomarker for a variety of diseases.

Overall, KCTD15 is a protein that is of interest as a potential drug target and biomarker. Further research is needed to fully understand its role in the regulation of cellular processes and its potential as a new drug or biomarker.

Protein Name: Potassium Channel Tetramerization Domain Containing 15

Functions: During embryonic development, interferes with neural crest formation (By similarity). Inhibits AP2 transcriptional activity by interaction with its activation domain

The "KCTD15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCTD15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets